- US-listed companies
- BIOLASE, INC
- Balance sheet
BIOLASE, INC【BIOLQ】Balance sheet
Market cap
$36.6
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Cash and cash equivalents | 3 | 3 | 1 | 32 | 12 | 9 | 12 | 8 | 6 | 18 | 30 | 4 | 7 |
| Total cash & short-term investments | 3 | 3 | 1 | 32 | 12 | 9 | 12 | 8 | 6 | 18 | 30 | 4 | 7 |
| Accounts receivable, net | 9 | 12 | 11 | 9 | 9 | 10 | 10 | 11 | 9 | 3 | 4 | 6 | 6 |
| Inventories | 11 | 11 | 11 | 13 | 13 | 14 | 12 | 12 | 11 | 11 | 13 | 16 | 11 |
| Total current assets | 25 | 27 | 26 | 55 | 35 | 34 | 36 | 33 | 27 | 35 | 49 | 29 | 25 |
| Property, plant and equipment, net | 1 | 2 | 2 | 1 | 4 | 4 | 4 | 2 | 1 | 1 | 1 | 4 | 6 |
| Total non-current assets | 4 | 5 | 5 | 5 | 7 | 8 | 7 | 5 | 5 | 6 | 6 | 9 | 10 |
| Total assets | 30 | 32 | 31 | 59 | 42 | 42 | 43 | 39 | 32 | 41 | 55 | 38 | 35 |
| Accounts payable | 8 | 8 | 9 | 8 | 6 | 9 | 5 | 6 | 5 | 3 | 3 | 6 | 6 |
| Long-term debt, current | - | - | - | - | - | - | - | - | 13 | - | - | - | - |
| Total current liabilities | 16 | 19 | 22 | 16 | 15 | 18 | 13 | 16 | 26 | 11 | 14 | 18 | 20 |
| Long-term debt, non-current | - | - | - | - | - | - | - | 11 | - | 16 | - | - | - |
| Total non-current liabilities | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 11 | 2 | 20 | 16 | 15 | 13 |
| Total liabilities | 17 | 20 | 23 | 17 | 17 | 20 | 14 | 27 | 28 | 31 | 30 | 33 | 33 |
| Common stock and paid-in capital | 139 | 141 | 149 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained earnings | -109 | -112 | -124 | -143 | -163 | -178 | -195 | -217 | -235 | -251 | -268 | -296 | -317 |
| Stockholders' equity | 13 | 12 | 8 | 42 | 25 | 22 | 29 | 11 | 0 | 10 | 25 | 5 | -0 |
| Total debt | - | - | - | - | - | - | - | 11 | 13 | 16 | - | - | - |
| Net debt | - | - | - | - | - | - | - | 2 | 7 | -2 | - | - | - |
| D/E ratio (%) | - | - | - | - | - | - | - | 97.7 | 3,571.9 | 161.4 | - | - | - |
| Working capital |